Logo image of CND.U

CONCORD ACQUISITION CORP (CND.U) Stock Price, Quote, News and Overview

NYSE:CND.U - New York Stock Exchange, Inc. - US2060712013 - Currency: USD

10.17  +0.01 (+0.1%)

Fundamental Rating

2

Overall CND.U gets a fundamental rating of 2 out of 10. We evaluated CND.U against 0 industry peers in the Unkown industry. While CND.U seems to be doing ok healthwise, there are quite some concerns on its profitability. CND.U has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CND.U had positive earnings in the past year.
CND.U had a negative operating cash flow in the past year.
CND.U Yearly Net Income VS EBIT VS OCF VS FCFCND.U Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 -5M -10M -15M -20M -25M

1.2 Ratios

Industry RankSector Rank
ROA 6.44%
ROE 6.71%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CND.U Yearly ROA, ROE, ROICCND.U Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 -2 -4 -6 -8 -10

1.3 Margins

CND.U does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CND.U Yearly Profit, Operating, Gross MarginsCND.U Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for CND.U remains at a similar level compared to 1 year ago.
CND.U has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CND.U Yearly Shares OutstandingCND.U Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 10M 20M 30M
CND.U Yearly Total Debt VS Total AssetsCND.U Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 19.36 indicates that CND.U is not in any danger for bankruptcy at the moment.
CND.U has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 19.36
ROIC/WACCN/A
WACCN/A
CND.U Yearly LT Debt VS Equity VS FCFCND.U Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 0.14 indicates that CND.U may have some problems paying its short term obligations.
CND.U has a Quick Ratio of 0.14. This is a bad value and indicates that CND.U is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14
CND.U Yearly Current Assets VS Current LiabilitesCND.U Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 500K 1M

More info and screens

1

3. Growth

3.1 Past

CND.U shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 225.46%, which is quite impressive.
EPS 1Y (TTM)225.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%169.91%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.94 indicates a rather expensive valuation of CND.U.
Compared to an average S&P500 Price/Earnings ratio of 27.30, CND.U is valued a bit cheaper.
Industry RankSector Rank
PE 19.94
Fwd PE N/A
CND.U Price Earnings VS Forward Price EarningsCND.U Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CND.U Per share dataCND.U EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CND.U does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONCORD ACQUISITION CORP

NYSE:CND.U (12/7/2022, 7:30:57 PM)

10.17

+0.01 (+0.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)03-02 2023-03-02
Inst Owners0.28%
Inst Owner Change-10.24%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap358.51M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 19.94
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.33
EV/EBITDA N/A
EPS(TTM)0.51
EY5.01%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS7.64
TBVpS7.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.44%
ROE 6.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z 19.36
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)225.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%169.91%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-81.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.69%
OCF growth 3YN/A
OCF growth 5YN/A